
主/次 診斷碼 診斷名稱 注記 
M Z00.00 Encounter for general adult medical examination without abnormal findings  
 
 

類別 醫令碼 醫令名稱 量 帳 急 日期 狀態 特殊醫囑 開立者 
治療 00009500 口腔黏膜檢查 (30歲以上嚼/戒檳榔或吸煙者/每2年1次) 1  N 2016/03/31 執行、已批 完成：2016/03/31
 章浩宏 
 

主/次 診斷碼 診斷名稱 注記 
M Z00.00 Encounter for general adult medical examination without abnormal findings  
 
 

類別 醫令碼 醫令名稱 量 帳 急 日期 狀態 特殊醫囑 開立者 
檢驗 00008500 定量免疫法糞便潛血檢查(50歲以上至未滿75歲者每2年1次) 1  N 2016/03/31 報到、已批 Specimen:STO
 陳恒順 
 

Subjective 
69 y/o man,
COPD with exacerbation and secondary infection
Hospitalized 2016/3/17-3/26
mild cough and sputum
minimal dyspnea
no SABA rescue needed.
BPH symptoms (+) not deteriorated after Spiriva
smoking for 40 years, 1 PPD, quit recently 
Objective 
Chest: some inspiratory rhonchi 
Plan 
Keep Spiriva
Berotec for rescue
Spirometry for COPD severity evaluation
monitor urination symptoms 
 
 
 

主/次 診斷碼 診斷名稱 注記 
M J44.9 Chronic obstructive pulmonary disease 慢 職  
O N40.0 Benign prostatic hyperplasia 慢 男  
 

商品名 劑量 頻率 途徑 天數 總量 記帳 連續 日期 狀態 開立者  
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 14 28 tab 健保  2016/03/31 已確認 已批 郭律成  
 

類別 醫令碼 醫令名稱 量 帳 急 日期 狀態 特殊醫囑 開立者 
檢查 17003C0S Screening (Flow-volume curve)-一般肺量測定 1  N 2016/03/31 執行、已批 完成：2016/04/07
 郭律成 
行政費用 000O1001 掛號費 1 自費 N 2016/03/31 已批 完成：2016/03/31  
行政費用 00156A00 一般門診診察費－就診人次在合理量 1  N 2016/03/31 已批 完成：2016/03/31  
行政費用 05205A00 門診藥事服務費(一般性處方給藥１４～２７天) 1  N 2016/03/31 已批 完成：2016/03/31 
 

Subjective 
69 y/o man,
COPD with exacerbation and secondary infection
Hospitalized 2016/3/17-3/26
mild cough and sputum
minimal dyspnea
no SABA rescue needed.
BPH symptoms (+) not deteriorated after Spiriva
smoking for 40 years, 1 PPD, quit recently
-----------------
exacerbation once, triggered by environmental dirt
nearly subsided now.
no URI symptoms 
Objective 
Chest: clear BS
【20160407】Pulmonary Function Test :
C(L)  2.9  2.96  97.9    
FEV1(L)  1.78  2.32  76.8    
FEV1/FVC(%)  61.4  77.4   
* Mild obstructive ventilatory defect 
Plan 
Keep Spiriva
Berotec for rescue
Spirometry for COPD severity evaluation
monitor urination symptoms 
 
 
 

主/次 診斷碼 診斷名稱 注記 
M J44.9 Chronic obstructive pulmonary disease 慢 職  
O N40.0 Benign prostatic hyperplasia 慢 男  
 

商品名 劑量 頻率 途徑 天數 總量 記帳 連續 日期 狀態 開立者  
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 28 56 tab 健保 3 2016/04/14 已確認 已批 郭律成  
Berotec N MA 100 mcg/1 puff 200 puff/btl 1 puff PRN IH 28 1 btl 健保  2016/04/14 已確認 已批 郭律成  
Spiriva Respimat Soln for Inh 2.5 mcg/1 puff 60 puff/btl 2 puff QD IH 28 1 btl 健保 3 2016/04/14 已確認 已批 郭律成 
 

Subjective 
69 y/o man,
COPD with exacerbation and secondary infection
Hospitalized 2016/3/17-3/26
mild cough and sputum
minimal dyspnea
no SABA rescue needed.
BPH symptoms (+) not deteriorated after Spiriva
smoking for 40 years, 1 PPD, still smoking recently
-----------------
quit medication for several months.
exacerbation with hospitalization 2016/10/13-10/22
admitted to ICU. respiratory failure
extubated then
mild cough and dyspnea
intermittent chest tingling pain (related to CAD?)
one episode of dyspnea attack. responsive to SABA rescue. 
Objective 
Chest: clear BS
【20160407】Pulmonary Function Test :
C(L)  2.9  2.96  97.9    
FEV1(L)  1.78  2.32  76.8    
FEV1/FVC(%)  61.4  77.4   
* Mild obstructive ventilatory defect 
Assessment 
COPD, group D 
Plan 
COPD treatment: triple therapy
Berotec for rescue
monitor urination symptoms 
 
 
 

主/次 診斷碼 診斷名稱 注記 
M J44.9 Chronic obstructive pulmonary disease 慢 職  
O N40.1 Enlarged prostate with lower urinary tract symptoms 慢 男  
 

商品名 劑量 頻率 途徑 天數 總量 記帳 連續 日期 狀態 開立者  
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 28 56 tab 健保 3 2016/11/17 已確認 已批 郭律成  
Relvar Ellipta Inh Powder 30 dose/box (遞送劑量92/22mcg) 1 dose QD IH 28 1 box 健保 3 2016/11/17 已確認 已批 郭律成  
Spiriva Respimat Soln for Inh 2.5 mcg/1 puff 60 puff/btl 2 puff QD IH 28 1 btl 健保 3 2016/11/17 已確認 已批 郭律成  
Medicon 15 mg/tab 1 tab TIDPC PO 7 21 tab 健保  2016/11/17 已確認 已批 郭律成 
 

Subjective 
69 y/o man,
COPD with exacerbation and secondary infection
Hospitalized 2016/3/17-3/26
mild cough and sputum
minimal dyspnea
no SABA rescue needed.
BPH symptoms (+) not deteriorated after Spiriva
smoking for 40 years, 1 PPD, still smoking recently
-----------------
quit medication for several months.
exacerbation with hospitalization 2016/10/13-10/22
admitted to ICU. respiratory failure
extubated then
mild cough and dyspnea
intermittent chest tingling pain (related to CAD?)
one episode of dyspnea attack. responsive to SABA rescue. 
Objective 
Chest: clear BS
【20160407】Pulmonary Function Test :
C(L)  2.9  2.96  97.9    
FEV1(L)  1.78  2.32  76.8    
FEV1/FVC(%)  61.4  77.4   
* Mild obstructive ventilatory defect 
Assessment 
COPD, group D 
Plan 
COPD treatment: triple therapy
Berotec for rescue
monitor urination symptoms 
 
 
 

主/次 診斷碼 診斷名稱 注記 
M J44.9 Chronic obstructive pulmonary disease 慢 職  
O N40.1 Enlarged prostate with lower urinary tract symptoms 慢 男  
 

商品名 劑量 頻率 途徑 天數 總量 記帳 連續 日期 狀態 開立者  
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 28 56 tab 健保 3 2016/11/17 已確認 已批 郭律成  
Relvar Ellipta Inh Powder 30 dose/box (遞送劑量92/22mcg) 1 dose QD IH 28 1 box 健保 3 2016/11/17 已確認 已批 郭律成  
Spiriva Respimat Soln for Inh 2.5 mcg/1 puff 60 puff/btl 2 puff QD IH 28 1 btl 健保 3 2016/11/17 已確認 已批 郭律成  
Medicon 15 mg/tab 1 tab TIDPC PO 7 21 tab 健保  2016/11/17 已確認 已批 郭律成 
 

Subjective 
69 y/o man,
COPD with exacerbation and secondary infection
Hospitalized 2016/3/17-3/26
mild cough and sputum
minimal dyspnea
no SABA rescue needed.
BPH symptoms (+) not deteriorated after Spiriva
smoking for 40 years, 1 PPD, still smoking recently
-----------------
quit medication for several months.
exacerbation with hospitalization 2016/10/13-10/22
admitted to ICU. respiratory failure
extubated then
mild cough and dyspnea
intermittent chest tingling pain (related to CAD?)
one episode of dyspnea attack. responsive to SABA rescue. 
Objective 
Chest: clear BS
【20160407】Pulmonary Function Test :
C(L)  2.9  2.96  97.9    
FEV1(L)  1.78  2.32  76.8    
FEV1/FVC(%)  61.4  77.4   
* Mild obstructive ventilatory defect 
Assessment 
COPD, group D 
Plan 
COPD treatment: triple therapy
Berotec for rescue
monitor urination symptoms 
 
 
 

主/次 診斷碼 診斷名稱 注記 
M J44.9 Chronic obstructive pulmonary disease 慢 職  
O N40.1 Enlarged prostate with lower urinary tract symptoms 慢 男  
 

商品名 劑量 頻率 途徑 天數 總量 記帳 連續 日期 狀態 開立者  
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 28 56 tab 健保 3 2016/11/17 已確認 已批 郭律成  
Relvar Ellipta Inh Powder 30 dose/box (遞送劑量92/22mcg) 1 dose QD IH 28 1 box 健保 3 2016/11/17 已確認 已批 郭律成  
Spiriva Respimat Soln for Inh 2.5 mcg/1 puff 60 puff/btl 2 puff QD IH 28 1 btl 健保 3 2016/11/17 已確認 已批 郭律成  
Medicon 15 mg/tab 1 tab TIDPC PO 7 21 tab 健保  2016/11/17 已確認 已批 郭律成 
 

Subjective 
69 y/o man,
COPD with exacerbation and secondary infection
Hospitalized 2016/3/17-3/26
mild cough and sputum
minimal dyspnea
no SABA rescue needed.
BPH symptoms (+) not deteriorated after Spiriva
smoking for 40 years, 1 PPD, still smoking recently
-----------------
quit medication for several months.
exacerbation with hospitalization 2016/10/13-10/22
admitted to ICU. respiratory failure
extubated then
----------------
visited ER on 11/21 because of dyspnea attack
improving. but stiil marked sneezing and rhinorrhea 
Objective 
Chest: expiratory rhonchi
【20160407】Pulmonary Function Test :
C(L)  2.9  2.96  97.9    
FEV1(L)  1.78  2.32  76.8    
FEV1/FVC(%)  61.4  77.4   
* Mild obstructive ventilatory defect 
Assessment 
COPD, group D 
Plan 
COPD treatment: triple therapy
Berotec for rescue
monitor urination symptoms 
 
 
 

主/次 診斷碼 診斷名稱 注記 
M J44.9 Chronic obstructive pulmonary disease 慢 職  
O N40.1 Enlarged prostate with lower urinary tract symptoms 慢 男  
 

商品名 劑量 頻率 途徑 天數 總量 記帳 連續 日期 狀態 開立者  
Predonine 5 mg/tab 2 tab BID PO 5 20 tab 健保  2016/11/28 已確認 已批 郭律成  
Berotec N MA 100 mcg/1 puff 200 puff/btl 1 puff PRN IH 7 1 btl 健保  2016/11/28 已確認 已批 郭律成  
Medicon 15 mg/tab 1 tab TIDPC PO 7 21 tab 健保  2016/11/28 已確認 已批 郭律成  
Allegra 60 mg/tab 1 tab BID PO 7 14 tab 健保  2016/11/28 已確認 已批 郭律成 
 
